Ajanta Pharma Limited vs Apollo Hospitals Enterprise Limited

A side-by-side comparison of Ajanta Pharma Limited (AJANTPHARM) and Apollo Hospitals Enterprise Limited (APOLLOHOSP) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Ajanta Pharma Limited leads AJANTPHARM vs APOLLOHOSP on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability40
  • Growth02
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

AJANTPHARM takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

39.28
P/E ratio
58.43
9.71
P/B ratio
13.46
0.91%
Dividend yield
0.22%
₹84.53
EPS
₹135.04

Profitability

AJANTPHARM takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

23.33%
Return on equity
20.48%
29.11%
Return on capital
17.31%
25.58%
EBITDA margin
14.94%
19.37%
Net margin
7.94%

Growth

APOLLOHOSP takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

13.37%
Revenue CAGR (3Y)
14.94%
21.55%
Profit CAGR (3Y)
33.35%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹41,525 Cr
Market cap
₹1.14L Cr
₹5,453 Cr
Revenue
₹25,229 Cr
₹1,056 Cr
Net profit
₹2,003 Cr
0.06
Debt / equity
0.90
Ajanta Pharma Limited
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 24.6%", "Company has been maintaining a healthy dividend payout of 33.1%", "Company is almost debt free."]
  • − ["Stock is trading at 9.17 times its book value"]
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Ajanta Pharma Limited full analysis Apollo Hospitals Enterprise Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.